Maternal inflammation during pregnancy is associated with risk of ADHD in children at age 10
Julie B Rosenberg1, Jens Richardt Møllegaard Jepsen2, Parisa Mohammadzadeh1
1Center for Neuropsychiatric Schizophrenia Research (CNSR) & Centre for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark; Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), Herlev and Gentofte Hospital, University of Copenhagen, Gentofte, Denmark; Faculty of Health and Medical Sciences, Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Insights
Prenatal maternal inflammation, measured by high-sensitivity C-Reactive Protein (hs-CRP), is linked to an increased risk of attention-deficit/hyperactivity disorder (ADHD) in children. This finding highlights inflammation as a potential target for improving neurodevelopmental outcomes.
Area of Science:
- Neurodevelopmental disorders
- Prenatal programming
- Inflammatory markers in pregnancy
Background:
- Maternal inflammation during pregnancy is hypothesized to impact offspring neurodevelopment.
- Clinical evidence linking prenatal inflammation to later childhood neurodevelopmental disorders like ADHD is limited.
- Previous studies suggest potential associations from preclinical and register data.
Purpose of the Study:
- To investigate the association between maternal inflammation levels during pregnancy and the risk of ADHD diagnosis in offspring.
- To examine the relationship between maternal inflammation and the severity of ADHD symptoms in children at age 10.
- To assess the clinical relevance of prenatal inflammation as a risk factor for ADHD.
Main Methods:
- Prospective study of 700 mother-child pairs in the COPSAC2010 cohort, followed since week 24 of gestation.
- Maternal high-sensitivity C-Reactive Protein (hs-CRP) levels measured at gestational week 24.
- Children underwent neurodevelopmental assessment at age 10, including ADHD diagnosis (K-SADS-PL) and symptom load (ADHD-RS), with adjustment for confounders.
Main Results:
- A total of 604 children (86%) participated in the age 10 assessment.
- Higher maternal hs-CRP levels were significantly associated with an increased risk of ADHD diagnosis (OR 1.40, p=0.001).
- Elevated maternal hs-CRP also correlated with a higher ADHD symptom load (ADHD-RS scores) in the children.
Conclusions:
- Prenatal maternal inflammation, indicated by hs-CRP, is robustly associated with ADHD diagnosis by age 10.
- Maternal inflammation during pregnancy is also linked to the dimensional aspect of ADHD symptom severity.
- Identifying inflammation as a marker offers potential targets for antenatal interventions to improve neurodevelopmental outcomes.
Introduction:
Maternal inflammation during pregnancy may affect early neurodevelopment in offspring as suggested by preclinical and register data. However, clinical evidence for risk of aberrant neurodevelopment later in childhood is scarce. In the population-based COPSAC2010 mother-child cohort, we investigated associations between maternal inflammation levels during pregnancy and the risk of a diagnosis of ADHD as well as the load of ADHD symptoms in the children at age 10.
Methods:
The COPSAC2010 cohort consists of 700 mother-child pairs followed prospectively since pregnancy week 24.Maternal high-sensitivity C-Reactive Protein (hs-CRP) level at week 24 of gestation was investigated in relation to child neurodevelopment by age 10 using logistic and linear regression models with extensive confounder adjustment, including socioeconomic status and maternal polygenic risk of ADHD. The children completed a comprehensive examination of neurodevelopment including categorical (i.e., diagnostic) and dimensional (i.e., symptom load) psychopathology using the Kiddie Schedule for Affective Disorders and Schizophrenia Present and Lifetime Version (K-SADS-PL) and parental rated ADHD-Rating Scale (ADHD-RS).
Results:
A total of 604 (86 %) of the 700 children in the COPSAC2010 cohort participated in the COPSYCH visit at age 10. Sixty-five (10.8 %) fulfilled a research diagnosis of ADHD (16 girls and 49 boys). Higher maternal hs-CRP level in pregnancy at week 24 (median 5.4 mg/L) was significantly associated with increased risk for a diagnosis of ADHD, adjusted OR 1.40, 95 %CI (1.16-1.70), p = 0.001. Additionally, higher maternal hs-CRP was associated with increased ADHD symptom load in the entire cohort, reflected by ADHD-RS raw scores.
Discussion:
These clinical data demonstrated a robust association of prenatal maternal inflammation assessed by hs-CRP with a diagnosis of ADHD by age 10. Moreover, maternal inflammation was associated with ADHD symptom load in the complete cohort. Identifying inflammation as an important marker will provide a potential target for future increased awareness and prevention during pregnancy thereby ultimately improving neurodevelopmental outcomes in children.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Environmental Influences on Intelligence
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Psychoneuroimmunology: Diabetes and Cancer
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...


